Metirox-10 Tablet

About Metirox-10 Tablet

Metirox-10 is a tablet containing methimazole, an anti-thyroid medicine. It is used to treat hyperthyroidism and to prepare patients for thyroid surgery or radioactive iodine therapy.

There are 5 brands of Methimazole listed in Bangladesh.

What is Metirox-10 Tablet?

Metirox-10 is a 10 mg tablet of methimazole, an anti-thyroid medicine from Renata PLC. It reduces the production of thyroid hormones and is used in Graves' disease or toxic multinodular goiter when surgery or radioactive iodine is not suitable. It is also used to ease hyperthyroid symptoms before thyroidectomy or radioactive iodine therapy. Methimazole does not inactivate thyroid hormones already stored in the body or circulating in the blood, and it does not interfere with thyroid hormones given by mouth or injection. The dose and course are decided by the doctor.

Uses of Metirox-10

Metirox-10 is used in adults with Graves' disease causing hyperthyroidism or with toxic multinodular goiter when surgery or radioactive iodine therapy is not an appropriate option. It is also used to reduce hyperthyroid symptoms in preparation for thyroidectomy or radioactive iodine therapy. It is an anti-thyroid medicine that works by reducing the synthesis of thyroid hormones. The doctor decides whether it is suitable and for how long it should be used.

How to use Metirox-10

Metirox-10 is taken by mouth. The doctor decides the dose, how often it is taken, and how long the course lasts. The total daily amount is usually divided into three doses taken at about eight-hour intervals, but this should be confirmed with your doctor or pharmacist. Do not change the dose or stop the medicine on your own. If you miss a dose, ask your doctor or pharmacist for advice. Swallow the tablet as directed.

Side effects of Metirox-10

Common side effects include skin rash, hives, nausea, vomiting, stomach discomfort, joint pain, tingling, loss of taste, hair loss, muscle pain, headache, itching, drowsiness, nerve inflammation, swelling, dizziness, skin pigmentation, jaundice, salivary gland swelling, and lymph node swelling. Rare but serious effects include low white blood cell counts, low platelets, aplastic anemia, drug fever, lupus-like syndrome, insulin autoimmune syndrome, hepatitis, and kidney inflammation. Seek medical advice if you notice unusual symptoms.

Safety and precautions

Metirox-10 is not for people with hypersensitivity to methimazole or any ingredient of the product. It can cross the placenta and may harm the fetus, especially in the first trimester, so other medicines may be preferred in pregnancy. It is excreted in breast milk; breastfeeding mothers should ask their doctor. Before starting, tell your doctor about pregnancy, breastfeeding, liver problems, blood disorders, or other medicines you take. The doctor will decide if it is safe for you and will monitor your progress.

Frequently asked questions

How should Metirox-10 be taken?

Metirox-10 is taken by mouth. The dose, frequency, and duration are decided by your doctor based on your condition. The daily amount is often divided into three doses at about eight-hour intervals, but follow your doctor's instructions exactly. Do not adjust the dose yourself.

What is Metirox-10 used for and what kind of medicine is it?

Metirox-10 is an anti-thyroid medicine containing methimazole. It is used to treat hyperthyroidism in Graves' disease or toxic multinodular goiter when surgery or radioactive iodine is not suitable, and to prepare patients for thyroid surgery or radioactive iodine therapy.

Which medicines may interact with Metirox-10?

Metirox-10 may interact with oral anticoagulants such as warfarin, beta-blockers, and digitalis glycosides. The effects of these medicines can change when thyroid function becomes normal. Tell your doctor about all medicines you take, including those without prescription, so your treatment can be adjusted safely.

Who should ask a doctor before using Metirox-10?

Pregnant or breastfeeding women, people with liver problems or blood disorders, and anyone allergic to methimazole should ask a doctor before using Metirox-10. The doctor will decide if this medicine is appropriate and will monitor for any problems during treatment.

Indications

Methimazole is indicated:
  • In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option.
  • To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.

Pharmacology

Methimazole inhibits the synthesis of thyroid hormones and thus is effective in the treatment of hyperthyroidism. The drug does not inactivate existing thyroxine and triiodothyronine that are stored in the thyroid or circulating in the blood nor does it interfere with the effectiveness of thyroid hormones given by mouth or by injection. Methimazole is readily absorbed in the gastrointestinal tract, metabolized in the liver, and excreted in the urine.

Dosage & Administration

Methimazole is administered orally. The total daily dosage is usually given in 3 divided doses at approximately 8 hour intervals.

Adults: The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8 hour intervals. The maintenance dosage is 5 to 15 mg daily.

Pediatric: Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8 hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.

Use in children & adolescents: Because of post-marketing reports of severe liver injury in pediatric patient treated with propylthiouracil, Methimazole is the preferred choice when an antithyroid drug is required for a pediatric patient.

Interaction

With medicine: Anticoagulants (oral)- Due to potential inhibition of vitamin K activity by methimazole, the activity of oral anticoagulants (e.g., warfarin) may be increased; additional monitoring of PT/INR should be considered, especially before surgical procedures. β-adrenergic blocking agents- Hyperthyroidism may cause an increased clearance of beta-blockers with a high extraction ratio. A dose reduction of beta-adrenergic blockers may be needed when a hyperthyroid patient becomes euthyroid. Digitalis glycosides- Serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid; a reduced dosage of digitalis glycosides may be needed. Theophylline- Theophylline clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid; a reduced dose of theophylline may be needed.

With food: Always take at the same moment in regard to meals, food may affect absorption unpredictably.

Contraindications

Methimazole is contraindicated in the presence of hypersensitivity to the drug or any of the other product components.

Side Effects

Common: Skin rash, urticaria, nausea, vomiting, epigastric distress, arthralgia, paresthesia, loss of taste, abnormal loss of hair, myalgia, headache, pruritus, drowsiness, neuritis, edema, vertigo, skin pigmentation, jaundice, sialadenopathy, and lymphadenopathy.

Rare: Agranulocytosis, granulocytopenia, thrombocytopenia and aplastic anemia, drug fever, a lupus-like syndrome, insulin autoimmune syndrome (which can result in hypoglycemic coma), hepatitis (jaundice may persist for several weeks after discontinuation of the drug), periarteritis, and hypoprothrombinemia. Nephritis occurs very rarely.

Pregnancy & Lactation

Pregnancy Category D. Due to the rare occurrence of congenital malformations associated with methimazole use, it may be appropriate to use other agents in pregnant women requiring treatment for hyperthyroidism particularly in the first trimester of pregnancy. Methimazole is excreted into breast milk. However, several studies found no effect on clinical status in nursing infants of mothers taking methimazole, particularly if thyroid function is monitored at frequent (weekly or biweekly) intervals.

Precautions & Warnings

Congenital Malformations: Methimazole readily crosses the placental membranes and can cause fetal harm, particularly when administered in the first trimester of pregnancy. If Methimazole is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be warned of the potential hazard to the fetus. Since some congenital defects have been reported in offspring of patients treated with Methimazole, it may be appropriate to use other agents in pregnant women requiring treatment for hyperthyroidism, particularly in the first trimester of pregnancy. If Methimazole is used, the lowest possible dose to control the disease should be given.

Agranulocytosis: Agranulocytosis is potentially a life-threatening adverse reaction of Methimazole therapy. Patients should be instructed to immediately report to their physicians if any symptoms suggestive of agranulocytosis, such as fever or sore throat occur. Leukopenia, thrombocytopenia, and aplastic anemia (pancytopenia) may also occur. The drug should be discontinued in the presence of agranulocytosis, aplastic anemia (pancytopenia), ANCA-positive vasculitis, hepatitis, or exfoliative dermatitis and the patient’s bone marrow indices should be monitored.

Liver Toxicity: Although there have been reports of hepatotoxicity associated with Methimazole, the risk of hepatotoxicity appears to be less with methimazole than with propylthiouracil, especially in the pediatric population. Drug treatment should be discontinued promptly in the event of clinically significant evidence of liver abnormality including hepatic transaminase values exceeding 3 times the upper limit of normal.

Hypothyroidism: Methimazole can cause hypothyroidism necessitating routine monitoring of TSH and free T4 levels with adjustments in dosing to maintain a euthyroid state. Because the drug readily crosses placental membranes, Methimazole can cause fetal goiter and cretinism when administered to a pregnant woman. For this reason, it is important that a sufficient, but not excessive, dose be given during pregnancy. Because Methimazole may cause hypoprothrombinemia and bleeding, prothrombin time should be monitored during therapy with the drug, especially before surgical procedures. Thyroid function tests should be monitored periodically during therapy. Once clinical evidence of hyperthyroidism has resolved, the finding of a rising serum TSH indicates that a lower maintenance dose of Methimazole should be employed.

Overdose Effects

Symptoms may include nausea, vomiting, epigastric distress, headache, fever, joint pain, pruritus, and edema. Aplastic anemia or agranulocytosis may be manifested in hours to days. Less frequent events are hepatitis, nephrotic syndrome, exfoliative dermatitis, neuropathies, and CNS stimulation or depression. In the event of an overdose, appropriate supportive treatment should be initiated as dictated by the patient’s medical status.

Storage Conditions

Store in a cool (below 30°C) and dry place, away from light and children.

Alternative brands of Methimazole

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.